Contact information
+44 (0)1865 857501
Tracey Walker
patoruryholman@dtu.ox.ac.uk
https://orcid.org/0000-0002-1256-874X
Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, OXFORD. OX3 7LJ
Rury Holman
MB, ChB. FRCP(Lon). FMedSci
Emeritus Professor of Diabetic Medicine
- Emeritus Diabetes Trials Unit Director
- Emeritus NIHR Senior Investigator
Rury Holman trained in medicine at the University of Bristol and was appointed Honorary Consultant Physician to the University of Oxford NHS Hospitals Trust in 1985, at which time he founded the University of Oxford Diabetes Trials Unit. He was appointed as the first Professor of Diabetic Medicine at the University of Oxford in 1998 and as the founding Academic Chairman of the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) in 2003. He is a Fellow of the Academy of Medical Sciences, an Emeritus NIHR Senior Investigator and Emeritus Professor of Diabetic Medicine. Professor Holman has won many distinguished international awards including the ADA Harold Rifkin Award for Distinguished International Service, the ADA Outstanding Achievement in Clinical Diabetes Research Award, the Diabetes UK Banting Memorial Lecture, the Diabetes UK Robert Turner Award for Research Impact and the ADA Banting Medal for Scientific Achievement Award.
Recent publications
Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study.
Journal article
Güdemann LM. et al, (2026), Lancet Reg Health Eur, 61
Estimating the risk of cardiovascular outcomes and all-cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL data.
Journal article
Coleman RL. et al, (2026), Diabetes Obes Metab, 28, 1068 - 1075
The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping Review.
Journal article
Goshrani A. et al, (2026), Diabetes Care, 49, 197 - 210
Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis.
Journal article
Bidel Z. et al, (2025), Eur Heart J
Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy.
Journal article
Standl E. et al, (2025), Cardiovasc Diabetol, 24
